Anticoagulation Flashcards
anticoagulant to use with history of HIT
argatroban
MOAs
UFH, LMWH, fondaparinux - bind to antithrombin
LMWH - inhibit factor Xa
warfarin - Vit. K agonist
direct thrombin inhibitors
do not cross react with HIT antibodies
argatroban - DOC if hx of HIT
bivalirudin (Angiomax)
dabigatran (Pradaxa) - oral - do not use with prosthetic valve - antidote: idarucizumab (Praxbind)
Factor Xa inhibitors
apixaban (Eliquis) betrixaban (Bevyxxa) edoxaban (Savaysa) rivaroxaban (Xarelto) fondaparinux - injectable do not require lab monitoring, no antidote do not use if prosthetic heart valve
UFH
binds to antithrombin, inactivates thrombin IIa and Xa, prevents conversion to fibrinogen
used to keep IV lines open
antidote: protamine
s/e: thromboxytopenia, HIT, hyperkalemia, osteoporosis
LMWH
bind to antithrombin, more affinity for Xa than IIa enoxaparin (Lovenox) dalteparin do not use with hx of HIT s/e: elevated LFTs, thrombocytopenia
HIT
immune mediated IgG rxn
Abs bind to heparin, lead to further platelet activation
can cause prothrombotic state = amputations
starts 5-14 days after herparin dose, w/in hours is heparin given in last 3 months
s/sx: unexplained drop in PLTs >50% of baseline
HIT treatment
stop all heparin and LMWH
stop warfarin, give Vit. K
if hx of HIT, use argatroban for anticoagulation
Warfarin
Coumadin, Jantoven
racemic mixture - S enantiomer more potent
c/i in pregnancy unless mech heart valve
goal 2-3, 2.5-3.5 if mech mitral valve
start dose: 10mg/day x2d, then adjust
in DVT/PE pts, continue enoxaparin/UFH x5d when starting warfarin
Warfarin interactions and genetics
2C9*2 or *3 or VCORC1 = increased bleed risk
2C9 inducers lower INR: rifampin, St. Jphn’s wort
2C9 inhibitors raise INR: amiodarone, fluconazole, Flagyl, Bactrim
decrease warfarin 30-50% if starting amiodarone
5 Gs increase bleeding: garlic, ginger, ginkgo, ginseng, glucosamine
Warfarin reversal
Vit. K, phytonadione (Mephyton), prothrombin concentrate (Kcentra)
supratherapeutic INR <4.5, no bleeding: reduce dose
INR 4.5-10, no bleed: hold 1-2 doses
INR >10, no bleed: hold, give Vit. K
major bleed: give IV Vit. K
perioperative warfarin (bridging therapy)
stop warfarin 5 days before surgery if mech valve, A-fib, VTE, embolism risk = bridging therapy w/ UFH or LMWH d/c LMWH 24 hrs before surgery d/c UFH 4-6 hrs before surgery resume warfarin 12-24 hrs after surgery
VTE prophylaxis
if can’t use anticoag: use pneumatic compression devices
VTE risk factors: surgery, trauma, immobility, cancer, VTE hx, pregnancy, estrogen meds, ESAs
for long-distance travelers: move frequently, compression, aspirin +anticoag should NOT be used
VTE treatment
pts w/o cancer: dabigatran and Xa inhibitors (rivaroxaban, apixaban, edoxaban) preferred over warfarin for first 3 months
cancer pts: LMWH preferred
Atrial Fibrillation
Rapid Ventricular Response
pts w/ mechanical valves get warfarin (2.5-3.5)
CHADS2-VASC scoring used
score 0 = no anticoag
score 1 = aspirin 75-325 daily or possible anticoag
score 2+ = anticoag (warfarin, dabigatran, rivaroxaban, apixaban) or aspirin + clopidogrel if unable to use anticoag